top of page

Xycrobe signs research deal with Johnson & Johnson Consumer

Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.

The collaboration, facilitated by Johnson & Johnson Innovation, is focused on further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page